Impax Laboratories Inc (IPXL)

[dickmilde]

IPXL Impax Laboratories Reports Significant Growth for the First Quarter 2010

First-Quarter Highlights (versus the prior year period)

The Company set multiple Financial Records in the First-Quarter

* Record total revenue of $323.3 million – up $264.4 million
* Generic Flomax® launched on March 2 added $176.2 million of revenue and $167.9 million of gross profit
* Record total gross profit of $243.8 million – up $211.1 million
* Gross profit margin increased to 75.4% - up from 55.4%
* Record income from operations of $211.0 million - up $206.8 million
* Record net income of $131.5 million – up $129.3 million
* Record earnings per diluted share of $2.06 – up $2.02

The earnings estimate was .49 for the quarter!

Dick Milde